Until now, SMA in India was curable only with the two most expensive and imported gene therapies -- Spinraza and Zolgensma -- from Biogen-Ionis and Novartis. Treatment for SMA costs over Rs 16-18 crore in India
India is an under-penetrated market when it comes to aviation. Just a fraction of the population currently travels by air. Airlines like IndiGo are already talking about taking away the market from railways by offering competitive fares
Lumine and Eclat Cardholders will earn 'Welcome Bonus Delight Points' of 1,000 and 1,500, respectively, on spending Rs 10,000 in 60 days from the date of the card issued
There are some significant structural changes that are taking place in the way we live and work, the way we bank, shop and interact with others, Uday Kotak writes to the shareholders
Earlier in the week, Shree Cement said it was investing over Rs 600 crore in West Bengal to set up a cement grinding unit. Other players are also making swift moves
According to the decision of Air India Specific Alternative Mechanism (AISAM) in 2018, disinvestment-bound Air India has been monetising its immovable assets to offset its debt
As Maldives and Malaysia have eased travel restrictions with India, Air India has announced new international flights connecting Indian cities with them
As part of second-quarter financial results released on Thursday, the approvals timetable indicates a USFDA approval application for COVID-19 Vaccine AstraZeneca SARS-CoV-2 (US) later in the year
